by Ombrello, Michael J, Arthur, Victoria L, Remmers, Elaine F, Hinks, Anne, Tachmazidou, Ioanna, Grom, Alexei A, Foell, Dirk, Martini, Alberto, Gattorno, Marco, Ozen, Seza, Prahalad, Sampath, Zeft, Andrew S, Bohnsack, John F, Ilowite, Norman T, Mellins, Elizabeth D, Russo, Ricardo, Len, Claudio, Odete e Hilario, Maria, Oliveira, Sheila, Yeung, Rae S. M, Rosenberg, Alan M, Wedderburn, Lucy R, Antón López, Jordi, Haas, Johannes-Peter, Rosen-Wolff, Angela, Minden, Kirsten, Tenbrock, Klaus, Demirkaya, Erkan, Cobb, Joanna, Baskin, Elizabeth, Signa, Sara, Shuldiner, Emily, Duerr, Richard H, Achkar, Jean-Paul, Kamboh, M. Ilyas, Kaufman, Kenneth M, Kottyan, Leah C, Pinto, Dalila, Scherer, Stephen W, Alarcón-Riquelme, Marta E, Docampo Martínez, Elisa, Estivill, Xavier, 1955, Gül, Ahmet, British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis (ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group Carl D Langefeld, Thompson, Susan, Zeggini, Eleftheria, Kastner, Daniel L, Woo, Patricia, Thomson, Wendy
Published in Annals of the rheumatic diseases (07.12.2016)